Search results for: 'nanoparticles pharma'

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...

03 Aug 2021  |  Global  |  Frost Radar

Frost Radar™: Global Membrane Water and Wastewater Treatment Market, 2021

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

Drought, harmful pollutants, and climate change are contributing to water stress around the world. Water utility and industrial water and wastewater treatment decision makers keep this and the circular economy in mind as they look for advanced, sustainable solutions that have minimal environmental impact and keep resources in a closed loop. Poly...

28 Aug 2020  |  Global  |  Technology Research

Data Science Impacting the Pharmaceutical Industry

Part I: Drug Discovery Applications

Infographics

×

Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire ...

In this report, Frost & Sullivan examines the role of artificial intelligence (AI) in the healthcare sector. Stakeholders across the healthcare continuum increasingly use AI to cater to the descriptive, diagnostic, predictive, and prescriptive aspects of care provision. These aspects help improve healthcare delivery efficiency, provide personalized...

04 Sep 2019  |  North America  |  Market Research

Strategic Analysis of the Global Automation and Control System Market in Life Sciences Industry, 2018

Continuous Manufacturing and Serialization Drive the Market due to the Need for Personalized Medicines

Infographics

×

Key Issues Addressed

The life science industry is on the verge of transformation due to the introduction of new product lines, increasing preference for personalized medicines and localized manufacturing, and high cost pressure. The industry needs the help of digitalization technologies to accelerate the journey of transformation. Increasing focus on improving process ...